These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6443768)
1. Activity of cefsulodin and other agents against Pseudomonas aeruginosa. Neu HC; Scully BE Rev Infect Dis; 1984; 6 Suppl 3():S667-77. PubMed ID: 6443768 [TBL] [Abstract][Full Text] [Related]
2. Comparative in-vitro activity of cefsulodin and ceftazidime against ticarcillin-resistant Pseudomonas aeruginosa. Philippon A; Paul G; Nevot P J Antimicrob Chemother; 1981 Sep; 8 Suppl B():119-22. PubMed ID: 19810173 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of cefsulodin against multi-resistant isolates of Pseudomonas aeruginosa. Qadri SM; Billington O; Cunha BA Drugs Exp Clin Res; 1991; 17(4):213-6. PubMed ID: 1794295 [TBL] [Abstract][Full Text] [Related]
4. Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa. Chandrasekar PH; Schell RF; LeFrock JL; Rolston KV; Francisco M Chemotherapy; 1984; 30(3):165-9. PubMed ID: 6428812 [TBL] [Abstract][Full Text] [Related]
5. Synergy with cefsulodin or piperacillin and three aminoglycosides or aztreonam against aminoglycoside resistant strains of Pseudomonas aeruginosa. Baltch AL; Bassey C; Hammer MC; Smith RP; Conroy JV; Michelsen PB J Antimicrob Chemother; 1991 Jun; 27(6):801-8. PubMed ID: 1938686 [TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Pseudomonas aeruginosa to beta-lactam antibiotics. Philippon A Chemioterapia; 1985 Dec; 4(6):424-8. PubMed ID: 3938346 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients. Chandrasekar PH; Crane LR; Bailey EJ J Antimicrob Chemother; 1987 Mar; 19(3):321-9. PubMed ID: 3106305 [TBL] [Abstract][Full Text] [Related]
8. [In vitro combination effects of astromicin and beta-lactam antibiotics against CFS-sensitive and CFS-resistant Pseudomonas aeruginosa. In vitro synergistic activity]. Yamada H; Takeyama H; Watanabe E; Fukutani H; Saka Y; Suzuki K; Kameyama Y; Esaki J; Yamazaki H; Mori Y Jpn J Antibiot; 1988 May; 41(5):478-84. PubMed ID: 3145991 [TBL] [Abstract][Full Text] [Related]
9. Effect of highly potent antipseudomonal beta-lactam agents alone and in combination with aminoglycosides against Pseudomonas aeruginosa. Lerner SA; Dudek EJ; Boisvert WE; Berndt KD Rev Infect Dis; 1984; 6 Suppl 3():S678-88. PubMed ID: 6443769 [TBL] [Abstract][Full Text] [Related]
10. Treatment of urinary tract infections due to Pseudomonas aeruginosa with cefsulodin. Elder HA; Roy I Rev Infect Dis; 1984; 6 Suppl 3():S734-43. PubMed ID: 6443774 [TBL] [Abstract][Full Text] [Related]
11. Synergistic activity of astromicin and beta-lactam antibiotics against Pseudomonas aeruginosa in vitro and in vivo. Kitaura K; Mineura K; Nakamizo N; Shiba K; Ohmori M; Saito A; Ueda Y J Antibiot (Tokyo); 1984 Dec; 37(12):1681-6. PubMed ID: 6441792 [TBL] [Abstract][Full Text] [Related]
12. Resistance of Pseudomonas aeruginosa to cefsulodin: modification of penicillin-binding protein 3 and mapping of its chromosomal gene. Gotoh N; Nunomura K; Nishino T J Antimicrob Chemother; 1990 Apr; 25(4):513-23. PubMed ID: 2112536 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa. Patzer J; Gieburowska R; Dzierzanowska D Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544 [TBL] [Abstract][Full Text] [Related]
14. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa. Perea EJ; Nogales MC; Aznar J; Martin E; Iglesias MC J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432 [No Abstract] [Full Text] [Related]
15. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams. Lerner SA; Quinn JP Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267 [TBL] [Abstract][Full Text] [Related]
16. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units]. Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273 [TBL] [Abstract][Full Text] [Related]
17. Experience with cefsulodin therapy for lower respiratory tract infections caused by Pseudomonas aeruginosa in adults without cystic fibrosis or granulocytopenia. Nichols L; Gudmundsson S; Maki DG Rev Infect Dis; 1984; 6 Suppl 3():S711-20. PubMed ID: 6443772 [TBL] [Abstract][Full Text] [Related]
18. Cefsulodin. Wright DB Drug Intell Clin Pharm; 1986 Nov; 20(11):845-9. PubMed ID: 3536385 [TBL] [Abstract][Full Text] [Related]
19. Cefsulodin in treatment of Pseudomonas urinary tract infection in patients with spinal cord injury. Comparison with aminoglycosides. Montgomerie JZ; Morrow JW; Canawati HN; Gilmore DS; Graham IE; Ibraham MZ Urology; 1986 Nov; 28(5):446-50. PubMed ID: 3787915 [TBL] [Abstract][Full Text] [Related]
20. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)]. Courtieu AL; Drugeon HB; Bryskier A; Chung SS; Reynaud A Pathol Biol (Paris); 1982 Jun; 30(6):432-9. PubMed ID: 6810287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]